Avanir Completes Successful Clinical Trial of Zenvia

California-based Avanir Pharmaceuticals recently announced the success of its drug Zenvia in reducing emotional outbursts associated with neurological disorders like ALS and Multiple Sclerosis. Zenvia was designed to treat pseudobulbar affect, a condition in which patients are prone to uncontrollable fits of laughter or tears. Nearly 2 million Americans with ALS, MS, or other neurological diseases suffer from the condition.

Click here to read more.

Share this:
Facebooktwittergoogle_plusmailFacebooktwittergoogle_plusmail